Ultragenyx Pharmaceutical Inc., Director, 10% Owner at Arcturus Therapeutics Holdings Inc. (ARCT), sold 1,600,000 shares at $94.97 ($161.3M) on 2020-12-09, disclosed to the SEC on 2020-12-10.
Open-market sale of $161.3M ARCT by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.54 | 442,255 | $46.7M | 28.9% |
| 2 | $105.54 | 442,255 | $46.7M | 28.9% |
| 3 | $94.97 | 357,745 | $34.0M | 21.1% |
| 4 | $94.97 | 357,745 | $34.0M | 21.1% |
| Total | $100.81 avg | 1,600,000 | $161.3M | 100% |